ZPD A/S: Financial statements 2016
CVR: 32834825
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
ZPD A/S (CVR 32834825) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 39,769,000 and a net result of DKK 10,929,000 compared with DKK 19,816,000 the year before. That is a decrease of 16.8% compared with the year before. Equity in the 2016 report amounted to DKK 134,926,000. The solvency ratio was 92.8%. The company had 28 employees in the financial year.
- Gross Profit
- DKK 39,769,000
- Profit/Loss
- DKK 10,929,000
- Equity
- DKK 134,926,000
- Total Assets
- DKK 145,328,000
- Employees
- 28
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | 39.8 mio. | 10.9 mio. | 134.9 mio. | 28 |
| 2015 | - | 47.8 mio. | 19.8 mio. | 124 mio. | 27 |
| 2014 | - | 45.2 mio. | 17 mio. | 110.2 mio. | 28 |
| 2013 | - | 43.4 mio. | 16.2 mio. | 105.2 mio. | 27 |
Official annual report
Find more companies like ZPD A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
As of December 31, 2016, Frank Marek has stepped down as økonomidirektør of ZPD A/S.
As of August 1, 2016, Ryu Nakao is registered as director of ZPD A/S.
ZPD A/S has published its annual report for 2015. Gross profit came to DKK 47,779,000, and the net result was DKK 19,816,000.
As of March 31, 2016, Robert Villum Nielsen has stepped down as director of ZPD A/S.
About ZPD A/S
ZPD A/S is a Danish company of the type Aktieselskab based in Esbjerg, founded in 2010. The company is registered under the industry Fremstilling af farmaceutiske råvarer. The company was previously named BIOFAC ESBJERG A/S. The management consists of Frank Marek and Hiroyuki Shinya. The board consists of Masakazu Sakurai (chair), Frank Marek and Ken Motegi. The company is owned by Zeria Pharmaceutical Co. Ltd.. The company has 54 employees (2026). In 2025, the company reported a gross profit of DKK 52,704,000 and a net result of DKK 10,220,000 compared with DKK 12,864,000 the year before. Equity in the 2025 report amounted to DKK 217,641,000.